Gilead Sciences (United States)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
58%
Total
Publications
6.4K
Total Open
Publications
3.7K
Total
Citations
277K
Open Access
Percentage
58%
Total
Publications
6.4K
Total Open
Publications
3.7K
Total
Citations
277K
Breakdown
Publisher Open
20%
Both
29%
Other Platform Open
9%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
1.2K
Hybrid 25%
766
No Guarantees 35%
1.1K
Other Platform Open
Domain 79%
1.9K
Institution 43%
1.1K
Other Internet 10%
250
Preprint 5%
124
Public 3%
68
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2K |
doaj.org OAI-PMH Repository | Institution | 576 |
DOI | Other Internet | 173 |
Unknown Repository | Other Internet | 98 |
California Digital Library | Institution | 90 |
Figshare | Public | 63 |
bioRxiv | Preprint | 58 |
Europe PMC | Domain | 57 |
Research Square | Preprint | 35 |
kuleuven.be OAI-PMH Repository | Institution | 32 |